The Trump administration continues to take a controversial stance on the abortion debate by advocating for easier access to abortion pills online. This time, the focus is on legal battles surrounding state regulations in Idaho, Kansas, and Missouri, which are challenging extended access rules in federal courts in Texas due to concerns about their legal standing.
These states are disputing a 2016 FDA decision that permits the use of abortion medications for up to 10 weeks rather than the previous seven weeks, but the Justice Department contends that these challenges fall outside current legal frameworks.
Ally Beth Stucky expressed confusion about the administration’s motives, calling it “friendly” and suggesting that it seems determined to ensure access to abortion pills regardless of safety concerns.
Stucky has often emphasized the risks associated with abortion pills, arguing that they can result in severe complications. For instance, she pointed out that women may misjudge how far along they are in their pregnancy; mistakenly thinking they are eight weeks when they might actually be 18 weeks.
Moreover, a recent study by the American Foundation for Repair revealed that abortion drugs are more dangerous than previously acknowledged by the FDA. The study indicated that about 11.2% of over 150,000 women experience “severe adverse events” after taking mifepristone, one of the primary abortion medications.
These severe complications can include significant bleeding, a need for blood transfusions, visits to the emergency room, and even life-threatening conditions such as sepsis. Stucky noted, “Remember, these pills aren’t taken in clinics or hospitals; they are often used in private bathrooms without any medical oversight.”
The rate of serious side effects reported in the study is approximately 22 times higher than what the FDA currently states for the brand-name equivalent, Mifeprex, as of 2023.
Stucky remarked, “If any other medication had such a risk, it would be pulled off the shelves.” She continued, addressing the narratives surrounding the drugs, “People claim they are safe and effective. Sure, they’re effective at ending pregnancies, but at what cost to women’s health?”
